Abstract
We reported the brain proton magnetic resonance spectroscopy (MRS) findings in 27 Wilson’s disease (WD) patients treated more than 6 years in neurological (nWD) and hepatic (hWD) subgroups. We investigated four hWD patients, with no improvement and eight with marked improvement; and eight nWD patients with marked improvement and seven with no improvement of clinical status. In nWD patients with improvement the MRS showed significantly higher Cho/Cr, Glx/Cr ratios levels. In hWD patients with no improvement the lower Cho/Cr and in nWD significantly lower NAA/Cr and higher Cho/Cr and Lip/Cr ratios were detected. In nWD patients with improvement the spectroscopic pattern, can be related to gliosis. In patients with no neurological improvement a persistent neuronal dysfunction can occur, perhaps as a result of copper or iron deposition.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Explore related subjects
Discover the latest articles and news from researchers in related subjects, suggested using machine learning.References
Bonavita S, Di Salle F, Tedeschi G (1999) Proton MRS in neurological disorders. Eur J Radiol 30:125–131
Bottomley P (1986) Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci 508:333–348
Członkowska A, Galewicz A, Rodo M, Wehr H (1973) Observation on copper metabolism in Wilson’s disease. Acta Univ Carol Med 56:175–178
Haussinger D, Laubenberger J, vom Dahl S, Ernst T, Bayer S, Langer M, Gerok W, Henning J (1994) Proton magnetic resonance spectroscopy studies on human brain myo-inositol in hypo-osmolarity and hepatic encephalopathy. Gastroenterol 107:1475–1480
Hoogenraad T (1997) Wilson’s disease. WB. Saunders Company Ttd, London
Horoupian D, Sternlieb I, Scheinberg I (1988) Neuropathological findings in penicillamine—treated patients with Wilson’s disease. Clin Neuropathol 7:62–67
Kreis R, Ross B, Farrow N, Ackerman R (1992) Metabolic disorders of the brain in chronic hepatic encephalopathy detected with H-1 MR spectroscopy. Radiology 182:19–27
Lizardi-Cervera J, Almeda P, Guevara L, Uribe M (2003) Hepatic encephalopathy: a review. Ann Hepatol 2:122–130
Lucato LT, Barbosa M, Machado A, McKinney A, Bacheschi L, Scaff M, Cerri G, Leite C (2005) Proton MR spectroscopy in Wilson disease: analysis of 36 cases. Am J Neuroradiol 26:1066–1071
Medici V, Di Leo V, Lamboglia F, Bowlus C, Tseng S, D’Inca R, Irato P, Burra P, Martines D, Strunillo G (2007) Effect of penicillamine and zinc on iron metabolizm in Wilson’s disease. Scand J Gastroenterol 42:1495–1500
Page R, Davie F, MacManus D, Miszkiel K, Walshe J, Miller D (2004) Clinical correlation of brain MRI and MRS abnormalities in patients with Wilson’s disease. Neurology 63:638–643
Roh J, Lee T, Wie B (1994) Initial and follow up brain MRI findings and correlations with the clinical course in Wilson’s disease. Neurology 44:1064–1068
Sinha S, Taly B, Ravishankar S, Prashanth L, Venugopal K, Arunodaya G (2006) Wilson’s disease: cranial MRI observations and clinical correlations. Neuroradiology 48:613–621
Spahr L, Burkhard P, Grotzsch H, Hadengue A (2002) Clinical significance of basal ganglia alternations at brain MRI and 1H MRS in cirrhosis and role in the pathogenesis of hepatic encephalopathy. Metab Brain Dis 17:399–413
Tarnacka B, Szeszkowski W, Gołębiowski M, Członkowska A (2008) MR spectroscopy in monitoring the treatment of Wilson’s disease patients. Mov Disord 23:1560–1567
Taylor-Robinson SD, Sargentoni J, Marcus CD, Morgan MY, Bryant DJ (1994) Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy. Metab Brain Dis 9:347–359
Verma A, Saraswat V, Krishna R, Nath K, Thomas A, Gupta R (2008) In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure. Liver Int 1478:1095–1103
Acknowledgements
This work was supported by grant from the Polish Ministry of Education and Science (3P05B/119/23).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Tarnacka, B., Szeszkowski, W., Gołębiowski, M. et al. Brain proton magnetic spectroscopy in long-term treatment of Wilson’s disease patients. Metab Brain Dis 25, 325–329 (2010). https://doi.org/10.1007/s11011-010-9214-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11011-010-9214-x